These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anthelmintics for people with neurocysticercosis. Monk EJM; Abba K; Ranganathan LN Cochrane Database Syst Rev; 2021 Jun; 6(6):CD000215. PubMed ID: 34060667 [TBL] [Abstract][Full Text] [Related]
3. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. Proaño JV; Madrazo I; Avelar F; López-Félix B; Díaz G; Grijalva I N Engl J Med; 2001 Sep; 345(12):879-85. PubMed ID: 11565520 [TBL] [Abstract][Full Text] [Related]
4. Anthelmintics for people with neurocysticercosis. Abba K; Ramaratnam S; Ranganathan LN Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD000215. PubMed ID: 20238309 [TBL] [Abstract][Full Text] [Related]
5. Neurocysticercosis in pregnancy: a case initially diagnosed as eclampsia. Suarez VR; Iannucci TA Obstet Gynecol; 1999 May; 93(5 Pt 2):816-8. PubMed ID: 10912405 [TBL] [Abstract][Full Text] [Related]
6. Anthelmintics for people with neurocysticercosis. Abba K; Ramaratnam S; Ranganathan LN Cochrane Database Syst Rev; 2010 Jan; (1):CD000215. PubMed ID: 20091504 [TBL] [Abstract][Full Text] [Related]
7. Radiographic Improvement of Larval Cysts in Neurocysticercosis. Landzberg DR; Dhir A; Jillella DV Ann Neurol; 2021 Feb; 89(2):416-417. PubMed ID: 33051897 [No Abstract] [Full Text] [Related]
8. The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis. Romo ML; Wyka K; Carpio A; Leslie D; Andrews H; Bagiella E; Hauser WA; Kelvin EA; Trans R Soc Trop Med Hyg; 2015 Nov; 109(11):738-46. PubMed ID: 26433183 [TBL] [Abstract][Full Text] [Related]
9. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. Singhi P; Ray M; Singhi S; Khandelwal N J Child Neurol; 2000 Apr; 15(4):207-13. PubMed ID: 10805184 [TBL] [Abstract][Full Text] [Related]
10. Neurocysticercosis: migration and proliferation of cysticercus in a CSF valve. Djientcheu VD; Zona G; Rilliet B Br J Neurosurg; 2000 Apr; 14(2):135-7. PubMed ID: 10889887 [TBL] [Abstract][Full Text] [Related]
11. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Del Brutto OH; Roos KL; Coffey CS; García HH Ann Intern Med; 2006 Jul; 145(1):43-51. PubMed ID: 16818928 [TBL] [Abstract][Full Text] [Related]
12. Intramedullary spinal neurocysticercosis treated successfully with medical therapy. Ahmed S; Paul SP J Egypt Soc Parasitol; 2014 Dec; 44(3):661-4. PubMed ID: 25643507 [TBL] [Abstract][Full Text] [Related]
13. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel? Romo ML; Carpio A; Kelvin EA J Clin Pharmacol; 2014 Apr; 54(4):361-7. PubMed ID: 24443292 [TBL] [Abstract][Full Text] [Related]
14. [Neurocysticercosis complicating the treatment of cutaneous cysticercosis in a traveller]. Epelboin L; Klement E; Chemali N; Danis M; Bricaire E; Caumes E Bull Soc Pathol Exot; 2004 Nov; 97(4):250-2. PubMed ID: 17304744 [TBL] [Abstract][Full Text] [Related]
15. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial. Kaur S; Singhi P; Singhi S; Khandelwal N Pediatr Infect Dis J; 2009 May; 28(5):403-6. PubMed ID: 19325515 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic optimisation of the treatment of neurocysticercosis. Sotelo J; Jung H Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011 [TBL] [Abstract][Full Text] [Related]
17. Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. Matthaiou DK; Panos G; Adamidi ES; Falagas ME PLoS Negl Trop Dis; 2008 Mar; 2(3):e194. PubMed ID: 18335068 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Garcia HH; Gonzales I; Lescano AG; Bustos JA; Zimic M; Escalante D; Saavedra H; Gavidia M; Rodriguez L; Najar E; Umeres H; Pretell EJ; Lancet Infect Dis; 2014 Aug; 14(8):687-695. PubMed ID: 24999157 [TBL] [Abstract][Full Text] [Related]
19. Exploring the complex associations over time among albendazole treatment, cyst evolution, and seizure outcomes in neurocysticercosis. Carpio A; Chang M; Zhang H; Romo ML; Jaramillo A; Hauser WA; Kelvin EA Epilepsia; 2019 Sep; 60(9):1820-1828. PubMed ID: 31355931 [TBL] [Abstract][Full Text] [Related]
20. [Giant racemose subarachnoid and intraventricular neurocysticercosis: A case report]. Sanchez-Larsen A; Monteagudo M; Lozano-Setien E; Garcia-Garcia J Rev Argent Microbiol; 2015; 47(3):201-5. PubMed ID: 26321177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]